Aberrant expression of USP14 is associated with progression of various cancers, including colorectal carcinoma 26, hepatocellular carcinoma 44, pancreatic ductal adenocarcinoma 27, breast cancer 45, and gastric cancer 46. The gene discussed is USP14; the disease is breast carcinoma.